PYXS 8-K: SEC filing

Pyxis Oncology

Filed with the SEC on Nov 5, 2026 · accession 0001193125-26-448604

PYXS filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Pyxis Oncology issued a press release announcing its financial results for the quarter ended September 30, 2026, along with a corporate update.

For details, click here →How to read a 8-K →

Key details

RegistrantPyxis Oncology, Inc.

Principal financial and accounting officerJitendra Wadhane

✦ Ask GOAX AI about this filing — what it means for PYXS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PYXS?

Click here

Frequently asked questions

What did PYXS file with the SEC on Nov 5, 2026?

PYXS filed a 8-K (SEC filing). Pyxis Oncology issued a press release announcing its financial results for the quarter ended September 30, 2026, along with a corporate update.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other PYXS SEC filings

Get alerts when PYXS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

PYXS overview PYXS analysis PYXS news Latest SEC filings